1. Home
  2. SOGP vs NXL Comparison

SOGP vs NXL Comparison

Compare SOGP & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOGP
  • NXL
  • Stock Information
  • Founded
  • SOGP 2010
  • NXL 2010
  • Country
  • SOGP Singapore
  • NXL United States
  • Employees
  • SOGP N/A
  • NXL N/A
  • Industry
  • SOGP
  • NXL Medical Specialities
  • Sector
  • SOGP
  • NXL Health Care
  • Exchange
  • SOGP NYSE
  • NXL Nasdaq
  • Market Cap
  • SOGP 10.0M
  • NXL 10.0M
  • IPO Year
  • SOGP 2020
  • NXL 2022
  • Fundamental
  • Price
  • SOGP $1.96
  • NXL $3.11
  • Analyst Decision
  • SOGP
  • NXL Hold
  • Analyst Count
  • SOGP 0
  • NXL 1
  • Target Price
  • SOGP N/A
  • NXL N/A
  • AVG Volume (30 Days)
  • SOGP 46.6K
  • NXL 387.3K
  • Earning Date
  • SOGP 01-01-0001
  • NXL 03-26-2025
  • Dividend Yield
  • SOGP N/A
  • NXL N/A
  • EPS Growth
  • SOGP N/A
  • NXL N/A
  • EPS
  • SOGP N/A
  • NXL N/A
  • Revenue
  • SOGP $250,401,822.00
  • NXL $162,078.00
  • Revenue This Year
  • SOGP $37.39
  • NXL $56.86
  • Revenue Next Year
  • SOGP $3.88
  • NXL $167.44
  • P/E Ratio
  • SOGP N/A
  • NXL N/A
  • Revenue Growth
  • SOGP N/A
  • NXL 26.00
  • 52 Week Low
  • SOGP $1.49
  • NXL $0.25
  • 52 Week High
  • SOGP $6.70
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • SOGP 49.48
  • NXL 54.50
  • Support Level
  • SOGP $1.92
  • NXL $2.70
  • Resistance Level
  • SOGP $2.24
  • NXL $3.30
  • Average True Range (ATR)
  • SOGP 0.21
  • NXL 0.35
  • MACD
  • SOGP 0.01
  • NXL 0.06
  • Stochastic Oscillator
  • SOGP 37.81
  • NXL 78.57

About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)

Sound Group Inc is a world-wide audio-centric social and entertainment company. It Leverages broad product portfolio and in-house technologies, Sound Group caters to user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions world-wide.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: